• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

GSK shuffles execs and streamlines businesses as vaccines chief Connor heads for the exit

cafead

Administrator
Staff member
  • cafead   Oct 25, 2022 at 11:12: PM
via Now unburdened by its consumer health division, GSK is streamlining its drug and vaccines businesses and shuffling executives in turn.

On the quest to simplify its operations in a post-Haleon world, GSK is “bringing together our medicines and vaccines manufacturing networks, and equivalent commercial operations, in one place,” a company spokesperson said via email Tuesday.

article source